Aldeyra Therapeutics (ALDX) EPS (Basic) (2013 - 2026)
Aldeyra Therapeutics' (ALDX) quarterly EPS (Basic) came in at -$0.06 in Q1 2026, up 80.52% YoY from -$0.03 in Q1 2025, and up 48.11% on a QoQ basis from -$0.11 in Q4 2025.
Aldeyra Therapeutics (ALDX) EPS (Basic) (2013 - 2026) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 14 years of EPS (Basic) data on file, last reported at -$0.06 in Q1 2026.
- Quarterly EPS (Basic) rose 80.52% year-over-year to -$0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.57 (up 52.57% YoY) and the FY2025 annual result came in at -$0.64, up 35.08% from the prior year.
- EPS (Basic) grew to -$0.06 in Q1 2026, from -$0.11 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.06 in Q1 2026 to a low of -$0.71 in Q1 2023.
- A 5-year average of -$0.27 and a median of -$0.27 in 2024 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 80.73% in 2024, down 260.19% in 2024.
- Tracing ALDX's EPS (Basic) over 5 years: stood at -$0.23 in 2022, then soared by 66.98% to -$0.07 in 2023, then slumped by 260.19% to -$0.27 in 2024, then jumped by 58.82% to -$0.11 in 2025, then jumped by 48.11% to -$0.06 in 2026.
- The last three EPS (Basic) figures came in at -$0.06 (Q1 2026), -$0.11 (Q4 2025), and -$0.23 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 0.18 |
| 10 | Aldeyra Therapeutics | 94.40 Mn | 94.40 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.06 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.23 |
| Jun 30, 2025 | -0.17 |
| Mar 31, 2025 | -0.29 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.28 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.44 |
| Mar 31, 2023 | -0.71 |
| Dec 31, 2022 | -0.23 |
| Sep 30, 2022 | -0.33 |
| Jun 30, 2022 | -0.33 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.28 |
| Sep 30, 2021 | -0.47 |